Infront USA Tec 100 (all day)

WKN: A0AE1X / ISIN: US6311011026

Bid: 21.251,2 Ask: 21.251,2

Echtzeit-Preisindikation vom 07.01.2025 um 20:37 Uhr!

-1,37% 21.251,2

Infront

Zeitraum Zeitraum

Zeiteinheit

Vergleich mit Index

ISIN

Chart Style Chart Typ

Vergleichsreihen

Skalierung

Logarithmisch

Prozentual

Volumen

Volumen

Draw Chart

Indikatoren Gleitender Durchschnitt

Im Kursbereich

Technische Indikatoren

Infront USA Tec 100 (all day) Chart

07.12. 23:38 - www.globenewswire.com Class Action Announcement for Celsius Holdings, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Celsius Holdings, Inc. - Contact Kessler Topaz Meltzer & Check, LLP RADNOR, Pa., Dec. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP
07.12. 22:02 - www.aktiencheck.de BayWa Aktie: Ennismore Fund Management startet Short-Aktivitäten! München (www.aktiencheck.de) - Leerverkäufer Ennismore Fund Management Limited geht Netto-Leerverkaufsposition in Aktien der BayWa AG ein: Die Shortseller des Hedgefonds Ennismore
07.12. 22:00 - www.fool.com My Biggest Investing Mistake of 2024 Wasnt What Youd Expect, but Its a Mistake I Wont Be Repeating Next Year In August, I bought shares of Celsius Holdings (NASDAQ: CELH). I like the companys growth, improving profit margins, and impressive
07.12. 20:58 - www.globenewswire.com ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages TMC the metals company Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMC NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law
07.12. 20:01 - www.globenewswire.com Marqeta, Inc. Announcement: If You Have Suffered Losses in Marqeta, Inc. (NASDAQ: MQ), You Are Encouraged to Contact The Rosen Law Firm About Your Rights NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law
07.12. 18:30 - www.globenewswire.com Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Mechelen, Belgium; December 7, 2024, 18:30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced additional data from the ongoing
07.12. 17:35 - www.globenewswire.com ROSEN, LEADING INVESTOR COUNSEL, Encourages Warner Bros. Discovery, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBD NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law
07.12. 14:18 - www.proactiveinvestors.com US Gold gearing up for construction at CK Gold Project after securing funding, permits US Gold Corp (NASDAQ:USAU) founder Edward Karr spoke with Proactive about recent developments at its CK Gold Project in Wyoming,
07.12. 13:30 - www.proactiveinvestors.com Medicus Pharma CEO on basal-cell carcinoma trial progress Medicus Pharma (NASDAQ:MDCX, TSX-V:MDCX) provided an update on its phase two clinical trial for a novel non-invasive treatment targeting basal-cell...